Molecular diagnostics are crucial in neuro-oncology for optimizing brain tumor diagnosis and treatment in cancer patients by providing detailed genetic information that helps classify tumors, predict prognosis, and guide personalized treatment strategies. This CME will reflect towards approach moves beyond traditional histology, allowing for more precise and effective patient care along with survival outcomes..